The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

proactatherapeutics.com

Stage

Other Investors | Alive

About Proacta

Proacta, founded in 2001, is a biotechnology company that discovers and develops innovative small-molecule prodrugs that address critical, unmet needs in oncology. Its initial programs are focused on developing prodrugs to be selectively activated under hypoxic conditions within a solid tumor. It is a subsidiary of Proacta Therapeutics Ltd. It is based in San Diego, California.

Proacta Headquarter Location

San Diego, California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.